The DOI matches its Crossref record; 192 of the 192 references it cites were found in a registry or an index.
The neurotoxicity of iron, copper and manganese in Parkinson's and Wilson's diseases
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxygen toxicity, oxygen radicals, transition metals and disease
Halliwell, B., & Gutteridge, J. M. C. (1984) · Biochemical Journal · doi:10.1042/bj2190001 · Cited by 5,330
Iron, brain ageing and neurodegenerative disorders
Zecca, L., Youdim, M. B. H., Riederer, P., Connor, J. R., & Crichton, R. R. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1537 · Cited by 1,801
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383
The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene
Tanzi, R. E., Petrukhin, K., Chernov, I., Pellequer, J. L., Wasco, W., Ross, B., Romano, D. M., Parano, E., Pavone, L., Brzustowicz, L. M., et al. (1993) · Nature Genetics · doi:10.1038/ng1293-344 · Cited by 1,375
Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149
Metal-triggered Structural Transformations, Aggregation, and Fibrillation of Human α-Synuclein
Uversky, V. N., Li, J., & Fink, A. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105343200 · Cited by 1,103
DEXTER, D. T., CARAYON, A., JAVOY-AGID, F., AGID, Y., WELLS, F. R., DANIEL, S. E., LEES, A. J., JENNER, P., & MARSDEN, C. D. (1991) · Brain · doi:10.1093/brain/114.4.1953 · Cited by 1,043
Increased nigral iron content in postmortem parkinsonian brain
Dexter, D. T., Wells, F. R., Agid, F., Agid, Y., Lees, A. J., Jenner, P., & Marsden, C. D. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91361-4 · Cited by 963
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
Sofic, E., Riederer, P., Heinsen, H., Beckmann, H., Reynolds, G. P., Hebenstreit, G., & Youdim, M. B. H. (1988) · Journal of Neural Transmission · doi:10.1007/bf01244786 · Cited by 752
Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo
Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., Viswanath, V., Jacobs, R., Yang, L., Beal, M. F., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00126-0 · Cited by 620
Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease
Devos, D., Moreau, C., Devedjian, J. C., Kluza, J., Petrault, M., Laloux, C., Jonneaux, A., Ryckewaert, G., Garçon, G., Rouaix, N., et al. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5593 · Cited by 619
Copper and iron disorders of the brain
Madsen, E., & Gitlin, J. D. (2007) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094232 · Cited by 557
Hirsch, E. C., Brandel, J. ‐., Galle, P., Javoy‐Agid, F., & Agid, Y. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb08170.x · Cited by 537
Brain barrier systems: a new frontier in metal neurotoxicological research
Zheng, W., Aschner, M., & Ghersi-Egea, J.-F. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(03)00251-5 · Cited by 507
The role of mitochondria in cellular iron–sulfur protein biogenesis and iron metabolism
Lill, R., Hoffmann, B., Molik, S., Pierik, A. J., Rietzschel, N., Stehling, O., Uzarska, M. A., Webert, H., Wilbrecht, C., & Mühlenhoff, U. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.05.009 · Cited by 499
Occupational exposures to metals as risk factors for Parkinson's disease
Gorell, J. M., Johnson, C. C., Rybicki, B. A., Peterson, E. L., Kortsha, G. X., Brown, G. G., & Richardson, R. J. (1997) · Neurology · doi:10.1212/wnl.48.3.650 · Cited by 476
Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts
Jellinger, K. A. (2012) · Movement Disorders · doi:10.1002/mds.23795 · Cited by 451
Good, P. F., Olanow, C. W., & Perl, D. P. (1992) · Brain Research · doi:10.1016/0006-8993(92)91334-b · Cited by 427
Salazar, J., Mena, N., Hunot, S., Prigent, A., Alvarez-Fischer, D., Arredondo, M., Duyckaerts, C., Sazdovitch, V., Zhao, L., Garrick, L. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804373105 · Cited by 409
The Parkinson Study Group QE3 Investigators, Beal, M. F., Oakes, D., Shoulson, I., Henchcliffe, C., Galpern, W. R., Haas, R., Juncos, J. L., Nutt, J. G., Voss, T. S., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.131 · Cited by 408
Zecca, L., Gallorini, M., Schünemann, V., Trautwein, A. X., Gerlach, M., Riederer, P., Vezzoni, P., & Tampellini, D. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00186.x · Cited by 401
THE COPPER AND IRON CONTENT OF BRAIN AND LIVER IN THE NORMAL AND IN HEPATO-LENTICULAR DEGENERATION
CUMINGS, J. N. (1948) · Brain · doi:10.1093/brain/71.4.410 · Cited by 385
Wu, J., Forbes, J. R., Chen, H. S., & Cox, D. W. (1994) · Nature Genetics · doi:10.1038/ng0894-541 · Cited by 384
The role of ceruloplasmin in iron metabolism.
Roeser, H. P., Lee, G. R., Nacht, S., & Cartwright, G. E. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106460 · Cited by 365
Manganese and Parkinson’s Disease: A Critical Review and New Findings
Guilarte, T. R. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.0901748 · Cited by 357
The relevance of iron in the pathogenesis of Parkinson’s disease
Sian‐Hülsmann, J., Mandel, S., Youdim, M. B. H., & Riederer, P. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07132.x · Cited by 352
Transferrin and Iron in Normal, Alzheimer's Disease, and Parkinson's Disease Brain Regions
Loeffler, D. A., Connor, J. R., Juneau, P. L., Snyder, B. S., Kanaley, L., DeMaggio, A. J., Nguyen, H., Brickman, C. M., & LeWitt, P. A. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65020710.x · Cited by 334
Environmental risk factors for Parkinson’s disease and parkinsonism: the Geoparkinson study
Dick, F. D., De Palma, G., Ahmadi, A., Scott, N. W., Prescott, G. J., Bennett, J., Semple, S., Dick, S., Counsell, C., Mozzoni, P., et al. (2007) · Occupational and Environmental Medicine · doi:10.1136/oem.2006.027003 · Cited by 325
The Neuropathology of Manganese-Induced Parkinsonism
Perl, D. P., & Olanow, C. W. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31812503cf · Cited by 324
Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis
Jellinger, K., Kienzl, E., Rumpelmair, G., Riederer, P., Stachelberger, H., Ben‐Shachar, D., & Youdim, M. B. H. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08362.x · Cited by 313
Oxidative Stress in Alzheimer’s Disease: Why Did Antioxidant Therapy Fail?
Persson, T., Popescu, B. O., & Cedazo-Minguez, A. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/427318 · Cited by 312
Manganese and its Role in Parkinson’s Disease: From Transport to Neuropathology
Aschner, M., Erikson, K. M., Hernández, E. H., & Tjalkens, R. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8083-0 · Cited by 308
Welding-related parkinsonism: Clinical features, treatment, and pathophysiology
Racette, B. A., McGee-Minnich, L., Moerlein, S. M., Mink, J. W., Videen, T. O., & Perlmutter, J. S. (2001) · Neurology · doi:10.1212/wnl.56.1.8 · Cited by 303
Zheng, W., & Monnot, A. D. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.10.006 · Cited by 302
Ben‐Shachar, D., Eshel, G., Finberg, J. P. M., & Youdim, M. B. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb11444.x · Cited by 299
Welding-related parkinsonism: Clinical features, treatment, and pathophysiology
Sadak, A. H., & Schulz, P. E. (2001) · Neurology · doi:10.1212/wnl.57.9.1738-a · Cited by 299
Dg, G. (1984) · PubMed · Cited by 292
Finkelstein, M. M., & Jerrett, M. (2007) · Environmental Research · doi:10.1016/j.envres.2007.03.002 · Cited by 277
Individual dopaminergic neurons show raised iron levels in Parkinson disease
Oakley, A. E., Collingwood, J. F., Dobson, J., Love, G., Perrott, H. R., Edwardson, J. A., Elstner, M., & Morris, C. M. (2007) · Neurology · doi:10.1212/01.wnl.0000262033.01945.9a · Cited by 273
Sequestration of iron by Lewy bodies in Parkinson's disease
Castellani, R. J., Siedlak, S. L., Perry, G., & Smith, M. A. (2000) · Acta Neuropathologica · doi:10.1007/s004010050001 · Cited by 265
Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease
Ayton, S., Lei, P., Duce, J. A., Wong, B. X. W., Sedjahtera, A., Adlard, P. A., Bush, A. I., & Finkelstein, D. I. (2013) · Annals of Neurology · doi:10.1002/ana.23817 · Cited by 264
Brouillet, E. P., Shinobu, L., McGarvey, U., Hochberg, F., & Beal, M. F. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1042 · Cited by 262
Decreased ferritin levels in brain in Parkinson's disease
Dexter, D. T., Carayon, A., Vidailhet, M., Ruberg, M., Agid, F., Agid, Y., Lees, A. J., Wells, F. R., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb08814.x · Cited by 258
Zhang, W., Phillips, K., Wielgus, A. R., Liu, J., Albertini, A., Zucca, F. A., Faust, R., Qian, S. Y., Miller, D. S., Chignell, C. F., et al. (2011) · Neurotoxicity Research · doi:10.1007/s12640-009-9140-z · Cited by 257
Patterns of levels of biological metals in CSF differ among neurodegenerative diseases
Hozumi, I., Hasegawa, T., Honda, A., Ozawa, K., Hayashi, Y., Hashimoto, K., Yamada, M., Koumura, A., Sakurai, T., Kimura, A., et al. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.01.003 · Cited by 252
Complex I, iron, and ferritin in Parkinson's disease substantia nigra
Mann, V. M., Cooper, J. M., Daniel, S. E., Srai, K., Jenner, P., Marsden, C. D., & Schapira, A. H. V. (1994) · Annals of Neurology · doi:10.1002/ana.410360612 · Cited by 251
Copper transport to the brain by the blood-brain barrier and blood-CSF barrier
Choi, B.-S., & Zheng, W. (2009) · Brain Research · doi:10.1016/j.brainres.2008.10.056 · Cited by 250
Copper-related diseases: From chemistry to molecular pathology
Crisponi, G., Nurchi, V. M., Fanni, D., Gerosa, C., Nemolato, S., & Faa, G. (2010) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.12.018 · Cited by 249
Brain iron metabolism and its perturbation in neurological diseases
Crichton, R. R., Dexter, D. T., & Ward, R. J. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-010-0470-z · Cited by 248
Shachar, D. B., Kahana, N., Kampel, V., Warshawsky, A., & Youdim, M. B. H. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.09.005 · Cited by 246
Copper pathology in vulnerable brain regions in Parkinson's disease
Davies, K. M., Bohic, S., Carmona, A., Ortega, R., Cottam, V., Hare, D. J., Finberg, J. P. M., Reyes, S., Halliday, G. M., Mercer, J. F. B., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.034 · Cited by 244
The Mobilization of Iron from the Perfused Mammalian Liver by a Serum Copper Enzyme, Ferroxidase I
Osaki, S., Johnson, D. A., & Frieden, E. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62284-7 · Cited by 236
Brain iron metabolism: Neurobiology and neurochemistry
Ke, Y., & Qian, Z. M. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.07.009 · Cited by 236
YOUDIM, M. B. H., STEPHENSON, G., & SHACHAR, D. B. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.025 · Cited by 233
RAISED CEREBROSPINAL-FLUID COPPER CONCENTRATION IN PARKINSON'S DISEASE
Pall, H. S., Blake, D. R., Gutteridge, J. M., Williams, A. C., Lunec, J., Hall, M., & Taylor, A. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90827-0 · Cited by 230
Faucheux, B. A., Martin, M., Beaumont, C., Hauw, J., Agid, Y., & Hirsch, E. C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01923.x · Cited by 229
Iron in the basal ganglia in Parkinson's disease
Griffiths, P. D., Dobson, B. R., Jones, G. R., & Clarke, D. T. (1999) · Brain · doi:10.1093/brain/122.4.667 · Cited by 229
Interactions between excessive manganese exposures and dietary iron-deficiency in neurodegeneration
Erikson, K. M., Syversen, T., Aschner, J. L., & Aschner, M. (2005) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2004.12.053 · Cited by 227
Earle, K. M. (1968) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-196801000-00001 · Cited by 227
Histochemical Distribution of Non-Haem Iron in the Human Brain
Morris, C. M., Candy, J. M., Oakley, A. E., Bloxham, C. A., & Edwardson, J. A. (1992) · Cells Tissues Organs · doi:10.1159/000147312 · Cited by 218
Faucheux, B. A., Nillesse, N., Damier, P., Spik, G., Mouatt-Prigent, A., Pierce, A., Leveugle, B., Kubis, N., Hauw, J. J., & Agid, Y. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9603 · Cited by 218
Liver mitochondrial membrane crosslinking and destruction in a rat model of Wilson disease
Zischka, H., Lichtmannegger, J., Schmitt, S., Jägemann, N., Schulz, S., Wartini, D., Jennen, L., Rust, C., Larochette, N., Galluzzi, L., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45401 · Cited by 215
Tuschl, K., Mills, P. B., & Clayton, P. T. (2013) · International Review of Neurobiology · doi:10.1016/b978-0-12-410502-7.00013-2 · Cited by 211
Aschner, M., & Gannon, M. (1994) · Brain Research Bulletin · doi:10.1016/0361-9230(94)90204-6 · Cited by 208
Buiakova, O. I., Xu, J., Lutsenko, S., Zeitlin, S., Das, K., Das, S., Ross, B. M., Mekios, C., Scheinberg, I. H., & Gilliam, T. C. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.9.1665 · Cited by 208
Zecca, L., Wilms, H., Geick, S., Claasen, J.-H., Brandenburg, L.-O., Holzknecht, C., Panizza, M. L., Zucca, F. A., Deuschl, G., Sievers, J., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0361-7 · Cited by 205
DATATOP: A decade of neuroprotective inquiry
Shoulson, I., & Parkinson Study Group (1998) · Annals of Neurology · doi:10.1002/ana.410440724 · Cited by 201
Chronic manganese poisoning: Individual susceptibility and absorption of iron
Mena, I., Horiuchi, K., Burke, K., & Cotzias, G. C. (1969) · Neurology · doi:10.1212/wnl.19.10.1000 · Cited by 192
Glutamine Synthetase: The Major Mn(II) Enzyme in Mammalian Brain
(1984) · Current Topics in Cellular Regulation · doi:10.1016/b978-0-12-152824-9.50021-6 · Cited by 190
Iron metabolism in Parkinsonian syndromes
Berg, D., & Hochstrasser, H. (2006) · Movement Disorders · doi:10.1002/mds.21020 · Cited by 186
The start of a long debate on the Warnock report.
Deitch, R. (1984) · PubMed · Cited by 186
Environmental Factors in the Etiology of Parkinson's Disease
Tanner, C. M., Chen, B., Wang, W.-Z., Peng, M.-L., Liu, Z.-L., Liang, X.-L., Kao, L. C., Gilley, D. W., & Schoenberg, B. S. (1987) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100037835 · Cited by 184
Roos, P. M., Vesterberg, O., Syversen, T., Flaten, T. P., & Nordberg, M. (2013) · Biological Trace Element Research · doi:10.1007/s12011-012-9547-x · Cited by 184
Self-citationAlpha-Synuclein Is a Cellular Ferrireductase
Davies, P., Moualla, D., & Brown, D. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015814 · Cited by 183
Lucchini, R. G., Martin, C. J., & Doney, B. C. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8108-8 · Cited by 182
The toxic milk mouse is a murine model of Wilson disease
Theophilos, M. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.10.1619 · Cited by 180
Lucchini, R. G., Albini, E., Benedetti, L., Borghesi, S., Coccaglio, R., Malara, E. C., Parrinello, G., Garattini, S., Resola, S., & Alessio, L. (2007) · American Journal of Industrial Medicine · doi:10.1002/ajim.20494 · Cited by 179
Barnes, N., Tsivkovskii, R., Tsivkovskaia, N., & Lutsenko, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413840200 · Cited by 177
Role of the P-Type ATPases, ATP7A and ATP7B in brain copper homeostasis
Telianidis, J., Hung, Y. H., Materia, S., & Fontaine, S. L. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00044 · Cited by 176
Searching for a relationship between manganese and welding and Parkinson’s disease
Jankovic, J. (2005) · Neurology · doi:10.1212/01.wnl.0000166916.40902.63 · Cited by 175
Boll, M.-C., Alcaraz-Zubeldia, M., Montes, S., & Rios, C. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9610-3 · Cited by 173
Manganese (Mn) and Iron (Fe): Interdependency of Transport and Regulation
Fitsanakis, V. A., Zhang, N., Garcia, S., & Aschner, M. (2010) · Neurotoxicity Research · doi:10.1007/s12640-009-9130-1 · Cited by 172
Localization of copper and copper transporters in the human brain
Davies, K. M., Hare, D. J., Cottam, V., Chen, N., Hilgers, L., Halliday, G., Mercer, J. F. B., & Double, K. L. (2013) · Metallomics · doi:10.1039/c2mt20151h · Cited by 163
Ayton, S., & Lei, P. (2014) · BioMed Research International · doi:10.1155/2014/581256 · Cited by 161
Willis, A. W., Evanoff, B. A., Lian, M., Galarza, A., Wegrzyn, A., Schootman, M., & Racette, B. A. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq303 · Cited by 159
Nischwitz, V., Berthele, A., & Michalke, B. (2008) · Analytica Chimica Acta · doi:10.1016/j.aca.2008.08.018 · Cited by 159
Forte, G., Bocca, B., Senofonte, O., Petrucci, F., Brusa, L., Stanzione, P., Zannino, S., Violante, N., Alimonti, A., & Sancesario, G. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0124-0 · Cited by 158
Shoulson, I. (1998) · PubMed · Cited by 154
Cerebrospinal fluid levels of transition metals in patients with Parkinson's disease
Jiménez‐Jiménez, F. J., Molina, J. A., Aguilar, M. V., Meseguer, I., Mateos-Vega, C. J., González‐Muñoz, M. J., de Bustos, F., Martínez‐Salio, A., Pareja, M. O., Zurdo, M., et al. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050073 · Cited by 153
Manganese Flux Across the Blood–Brain Barrier
Yokel, R. A. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8101-2 · Cited by 151
Zaitone, S. A., Abo–Elmatty, D. M., & Shaalan, A. A. M. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.09.002 · Cited by 151
Occupational Metal Exposures and the Risk of Parkinson’s Disease
Gorell, J. M., Rybicki, B. A., Johnson, C. C., & Peterson, E. L. (1999) · Neuroepidemiology · doi:10.1159/000026225 · Cited by 150
Effect of ceruloplasmin on plasma iron in copper-deficient swine
Ragan, H. A., Nacht, S., Lee, G., Bishop, C., & Cartwright, G. (1969) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1969.217.5.1320 · Cited by 146
The role of transition metals in the pathogenesis of Parkinson's disease
Kienzl, E., Puchinger, L., Jellinger, K. A., Linert, W., Stachelberger, H., & Jameson, R. F. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00210-s · Cited by 145
Zhu, W., Xie, W., Pan, T., Xu, P., Fridkin, M., Zheng, H., Jankovic, J. J., Youdim, M. B. H., & Le, W. (2007) · The FASEB Journal · doi:10.1096/fj.07-8386com · Cited by 144
Ferritin as an important player in neurodegeneration
Friedman, A., Arosio, P., Finazzi, D., Koziorowski, D., & Gałązka-Friedman, J. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.03.016 · Cited by 143
Association study between iron-related genes polymorphisms and Parkinson's disease
Borie, C., Gasparini, F., Verpillat, P., Bonnet, A.-M., Agid, Y., Hetet, G., Brice, A., Dürr, A., & Grandchamp, B. (2002) · Journal of Neurology · doi:10.1007/s00415-002-0704-6 · Cited by 143
New insights into manganese toxicity and speciation
Michalke, B., & Fernsebner, K. (2013) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2013.08.005 · Cited by 142
Mapping metals in Parkinson's and normal brain using rapid-scanning x-ray fluorescence
Popescu, B. F. G., George, M. J., Bergmann, U., Garachtchenko, A., Kelly, M., McCrea, R. P. E., Luening, K., Devon, R. M., George, G. N., Hanson, A. D., et al. (2009) · Physics in Medicine and Biology · doi:10.1088/0031-9155/54/3/012 · Cited by 141
Temlett, J. A., Landsberg, J. P., Watt, F., & Orime, G. W. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62010134.x · Cited by 140
Jin, L., Wang, J., Zhao, L., Jin, H., Fei, G., Zhang, Y., Zeng, M., & Zhong, C. (2010) · Brain · doi:10.1093/brain/awq319 · Cited by 138
Pathophysiology of manganese-associated neurotoxicity
Racette, B. A., Aschner, M., Guilarte, T. R., Dydak, U., Criswell, S. R., & Zheng, W. (2011) · NeuroToxicology · doi:10.1016/j.neuro.2011.12.010 · Cited by 136
Stanwood, G. D., Leitch, D. B., Savchenko, V. L., Wu, J. Y., Fitsanakis, V. A., Anderson, D. J., Stankowski, J. N., Aschner, M., & McLaughlin, B. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06145.x · Cited by 136
Uitti, R. J., Rajput, A. H., Rozdilsky, B., Bickis, M., Wollin, T., & Yuen, W. K. (1989) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100029140 · Cited by 135
Olfactory uptake of manganese requires DMT1 and is enhanced by anemia
Thompson, K., Molina, R. M., Donaghey, T. C., Schwob, J. E., Brain, J. D., & Wessling‐Resnick, M. (2006) · The FASEB Journal · doi:10.1096/fj.06-6710com · Cited by 134
Mochizuki, H., Imai, H., Endo, K., Yokomizo, K., Murata, Y., Hattori, N., & Mizuno, Y. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90462-6 · Cited by 132
Twomey, P. J., Viljoen, A., House, I. M., Reynolds, T., & Wierzbicki, A. S. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.052688 · Cited by 131
Copper binding regulates intracellular alpha‐synuclein localisation, aggregation and toxicity
Wang, X., Moualla, D., Wright, J. A., & Brown, D. R. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06638.x · Cited by 127
Iron and reactive oxygen species activity in parkinsonian substantia nigra
del Nogal, A. W., Gałązka-Friedman, J., Bauminger, E. R., Wszołek, Z. K., Schweitzer, K. J., Dickson, D. W., Jaklewicz, A., Elbaum, D., & Friedman, A. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.02.007 · Cited by 126
Hudnell, H. K. (1999) · PubMed · Cited by 125
Stamelou, M., Tuschl, K., Chong, W. K., Burroughs, A. K., Mills, P. B., Bhatia, K. P., & Clayton, P. T. (2012) · Movement Disorders · doi:10.1002/mds.25138 · Cited by 125
Olivieri, S., Conti, A., Iannaccone, S., Cannistraci, C. V., Campanella, A., Barbariga, M., Codazzi, F., Pelizzoni, I., Magnani, G., Pesca, M., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3768-11.2011 · Cited by 125
Occupational Metal Exposures and the Risk of Parkinson’s Disease
Raterman, K. (2011) · Cited by 124
Facteurs environnementaux dans l'étiologie de la maladie de Parkinson
Zayed, J., Ducic, S., Campanella, G., Panisset, J.-C., André, P., Masson, H., & Roy, M. (1990) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100030584 · Cited by 124
Copper, Ceruloplasmin, Superoxide Dismutase and Iron Parameters in Parkinson's Disease
Tórsdóttir, G., Kristinsson, J., Sveinbjörnsdóttir, S., Snædal, J., & Jøhannesson, T. (1999) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1999.tb02015.x · Cited by 118
Faucheux, B. A., Martin, M., Beaumont, C., Hunot, S., Hauw, J., Agid, Y., & Hirsch, E. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01118.x · Cited by 116
Iron in parkinsonian and control substantia nigra—A mössbauer spectroscopy study
Gałązka-Friedman, J., Bauminger, E. R., Friedman, A., Barcikowska, M., Hechel, D., & Nowik, I. (1996) · Movement Disorders · doi:10.1002/mds.870110104 · Cited by 113
Griffiths, P. D., & Crossman, A. R. (1993) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000107298 · Cited by 113
Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease
Hochstrasser, H., Bauer, P., Walter, U., Behnke, S., Spiegel, J., Csoti, I., Zeiler, B., Bornemann, A., Pahnke, J., Becker, G., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000144276.29988.c3 · Cited by 111
Sengstock, G. J., Olanow, C. W., Menzies, R. A., Dunn, A. J., & Arendash, G. W. (1993) · Journal of Neuroscience Research · doi:10.1002/jnr.490350109 · Cited by 110
Stuerenburg, H. J. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050026 · Cited by 108
de Córdova, F. M., Aguiar, A. S., Peres, T. V., Lopes, M. W., Gonçalves, F. M., Pedro, D. Z., Lopes, S. C., Pilati, C., Prediger, R. D., Farina, M., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1017-5 · Cited by 107
Crossgrove, J. S. (2003) · NeuroToxicology · doi:10.1016/j.neuro.2003.10.005 · Cited by 104
Brain metal accumulation in Wilson's disease
Litwin, T., Gromadzka, G., Szpak, G. M., Jabłonka-Salach, K., Bulska, E., & Członkowska, A. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.03.021 · Cited by 104
Self-citationFernsebner, K., Zorn, J., Kanawati, B., Walker, A., & Michalke, B. (2014) · Metallomics · doi:10.1039/c4mt00022f · Cited by 103
Ferroportin1 and hephaestin are involved in the nigral iron accumulation of 6‐OHDA‐lesioned rats
Wang, J., Jiang, H. F., & Xie, J. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05515.x · Cited by 96
Effect of levodopa treatment for parkinsonism in welders
Koller, W. C., Lyons, K. E., & Truly, W. (2004) · Neurology · doi:10.1212/01.wnl.0000113726.34734.15 · Cited by 94
Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease
Boll, M.-C., Sotelo, J., Otero, E., Alcaraz-Zubeldia, M., & Rios, C. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00221-9 · Cited by 92
Speciation and toxicological relevance of manganese in humans
Michalke, B., Halbach, S., & Nischwitz, V. (2007) · Journal of Environmental Monitoring · doi:10.1039/b704173j · Cited by 91
Associations of welding and manganese exposure with Parkinson disease: Review and meta-analysis
Mortimer, J. A., Borenstein, A. R., & Nelson, L. M. (2012) · Neurology · doi:10.1212/wnl.0b013e3182698ced · Cited by 89
Fored, C. M., Fryzek, J. P., Brandt, L., Nise, G., Sjögren, B., McLaughlin, J. K., Blot, W. J., & Ekbom, A. (2006) · Occupational and Environmental Medicine · doi:10.1136/oem.2005.022921 · Cited by 89
Metal changes in CSF and peripheral compartments of parkinsonian patients
Bocca, B., Alimonti, A., Senofonte, O., Pino, A., Violante, N., Petrucci, F., Sancesario, G., & Forte, G. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.05.007 · Cited by 88
Bornhorst, J., Wehe, C. A., Hüwel, S., Kärst, U., Galla, H., & Schwerdtle, T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.344093 · Cited by 85
Enhanced Autophagy from Chronic Toxicity of Iron and Mutant A53T α-Synuclein
Chew, K. C. M., Ang, E., Tai, Y. K., Tsang, F., Lo, S. Q., Ong, E., Ong, W.-Y., Shen, H., Lim, K., Dawson, V. L., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.268409 · Cited by 84
Iron-dependent functions of mitochondria—relation to neurodegeneration
Gille, G., & Reichmann, H. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0503-7 · Cited by 81
Metals in alzheimer's disease: a systemic perspective
Squitti, R. (2011) · Frontiers in bioscience · doi:10.2741/3938 · Cited by 80
Elemental profile of cerebrospinal fluid in patients with Parkinson's disease
Alimonti, A., Bocca, B., Pino, A., Ruggieri, F., Forte, G., & Sancesario, G. (2007) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2007.05.001 · Cited by 80
Regional siderosis: a new challenge for iron chelation therapy
Cabantchik, Z. I., Münnich, A., Youdim, M. B. H., & Devos, D. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00167 · Cited by 70
Compound overload of copper and iron in patients with Wilson's disease
Hayashi, H., Yano, M., Fujita, Y., & Wakusawa, S. (2006) · Medical Molecular Morphology · doi:10.1007/s00795-006-0326-7 · Cited by 69
Manganese speciation using capillary electrophoresis–ICP-mass spectrometry
Michalke, B. (2004) · Journal of Chromatography A · doi:10.1016/j.chroma.2004.05.076 · Cited by 69
Voltage-gated Calcium Channels Provide an Alternate Route for Iron Uptake in Neuronal Cell Cultures
Gaasch, J. A., Geldenhuys, W. J., Lockman, P. R., Allen, D. D., & der Schyf, C. J. V. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9313-1 · Cited by 68
Fritzsch, D., Reiss-Zimmermann, M., Trampel, R., Turner, R., Hoffmann, K., & Schäfer, A. (2013) · Investigative Radiology · doi:10.1097/rli.0000000000000010 · Cited by 67
Wang, X., Li, G. J., & Zheng, W. (2006) · Brain Research · doi:10.1016/j.brainres.2006.04.046 · Cited by 67
Manganese toxicokinetics at the blood-brain barrier.
Yokel, R. A., & Crossgrove, J. S. (2004) · PubMed · Cited by 64
Dopaminergic cell death precedes iron elevation in MPTP-injected monkeys
He, Y., Thong, P. S. P., Lee, T. T., Leong, S. K., Mao, B. Y., Dong, F., & Watt, F. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00385-x · Cited by 63
Lower serum ceruloplasmin levels correlate with younger age of onset in Parkinson’s disease
Bharucha, K. J., Friedman, J. H., Vincent, A. S., & Ross, E. D. (2008) · Journal of Neurology · doi:10.1007/s00415-009-0063-7 · Cited by 63
Brain copper, iron, magnesium, zinc, calcium, sulfur and phosphorus storage in Wilson's disease
Faa, G., Lisci, M., Caria, M. P., Ambu, R., Sciot, R., Nurchi, V. M., Silvagni, R., Diaz, A., & Crisponi, G. (2001) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/s0946-672x(01)80060-2 · Cited by 62
Michalke, B., Berthele, A., Mistriotis, P., Ochsenkühn-Petropoulou, M. T., & Halbach, S. (2007) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2007.09.004 · Cited by 59
α-Synuclein as a ferrireductase
Brown, D. R. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130130 · Cited by 58
Visanji, N. P., Collingwood, J. F., Finnegan, M. E., Tandon, A., House, E. R., & Hazrati, L. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-130197 · Cited by 57
Genetics and iron in the systems biology of Parkinson’s disease and some related disorders
Funke, C., Schneider, S. A., Berg, D., & Kell, D. B. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.11.015 · Cited by 57
Self-citationDMT1 polymorphism and risk of Parkinson's disease.
He, Q., Du, T., Yu, X., Xie, A., Song, N., Kang, Q., Yu, J.-T., Tan, L., Xie, J.-X., & Jiang, H. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.07.001 · Cited by 57
Allen, K. J., Buck, N. E., Cheah, D. M. Y., Gazeas, S., Bhathal, P. S., & Mercer, J. F. B. (2006) · BioMetals · doi:10.1007/s10534-005-5918-5 · Cited by 56
Manganese‐induced parkinsonism in methcathinone abusers: bio‐markers of exposure and follow‐up
Sikk, K., Haldre, S., Aquilonius, S., Asser, A., Paris, M., Roose, Ä., Petterson, J., Eriksson, S. ‐., Bergquist, J., & Taba, P. (2013) · European Journal of Neurology · doi:10.1111/ene.12088 · Cited by 55
Park, R. M. (2013) · Safety and Health at Work · doi:10.1016/j.shaw.2013.07.003 · Cited by 55
Increased cerebral iron uptake in Wilson's disease: a 52Fe-citrate PET study.
Bruehlmeier, M., Leenders, K. L., Vontobel, P., Calonder, C., Antonini, A., & Weindl, A. (2000) · PubMed · Cited by 55
Hininger, I., Waters, R., Osman, M., Garrel, C., Fernholz, K., Roussel, A. M., & Anderson, R. A. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.02.016 · Cited by 53
Identification of L-ferritin in Neuromelanin Granules of the Human Substantia Nigra
Tribl, F., Asan, E., Arzberger, T., Tatschner, T., Langenfeld, E., Meyer, H. E., Bringmann, G., Riederer, P. F., Gerlach, M., & Marcus, K. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900006-mcp200 · Cited by 53
Koizumi, M., Fujii, J., Suzuki, K., Inoue, T., Inoue, T., Gutteridge, J. M. C., & Taniguchi, N. (1998) · Free Radical Research · doi:10.3109/10715769809066881 · Cited by 49
Nigral iron deposition occurs across motor phenotypes of Parkinson’s disease
Jin, L., Wang, J., Jin, H. M., Fei, G.-J., Zhang, Y., Chen, W., Zhao, L., Zhao, N., Sun, X., Zeng, M., et al. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03658.x · Cited by 49
Jursa, T., & Smith, D. R. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn231 · Cited by 49
Iron as a cause of Parkinson disease – a myth or a well established hypothesis?
Friedman, A., Gałązka-Friedman, J., & Koziorowski, D. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70817-x · Cited by 47
Decreased iron levels in the temporal cortex in postmortem human brains with Parkinson disease
Yu, X., Du, T., Song, N., He, Q., Shen, Y., Jiang, H., & Xie, J. (2013) · Neurology · doi:10.1212/wnl.0b013e31827f0ebb · Cited by 46
Weisner, B., Hartard, C., & Dieu, C. (1987) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(87)90275-9 · Cited by 46
Peripheral iron dextran induced degeneration of dopaminergic neurons in rat substantia nigra
Jiang, H. F., Song, N., Wang, J., Ren, L., & Xie, J. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.03.006 · Cited by 45
Ceruloplasmin and superoxide dismutase (SOD1) in Parkinson's disease: A follow-up study
Tórsdóttir, G., Sveinbjörnsdóttir, S., Kristinsson, J., Snædal, J., & Jøhannesson, T. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.10.015 · Cited by 45
Ceruloplasmin and iron in Alzheimer’s disease and Parkinson’s disease: a synopsis of recent studies
Snædal, J., Kristinsson, J. R., Johannesson, & Tórsdóttir, G. (2012) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s34729 · Cited by 45
Morello, M., Zatta, P. F., Zambenedetti, P., Martorana, A., D’Angelo, V., Melchiorri, G., Bernardi, G., & Sancesario, G. (2007) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2007.07.011 · Cited by 44
Manganese mixture inhalation is a reliable Parkinson disease model in rats
Sánchez-Betancourt, J., Anaya-Martínez, V., Gutiérrez-Valdez, A. L., Ordóñez-Librado, J. L., Montiel-Flores, E., Espinosa-Villanueva, J., Erazo, L. R., & Ávila-Costa, M. R. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.08.012 · Cited by 44
Peng, F., Lutsenko, S., Sun, X., & Muzik, O. (2011) · Molecular Imaging and Biology · doi:10.1007/s11307-011-0532-0 · Cited by 43
Intranigral injected iron progressively reduces striatal dopamine metabolism
Wesemann, W., Blaschke, S., Solbach, M., Grote, C., Clement, H. ‐., & Riederer, P. F. (1994) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02260941 · Cited by 39
Manganese speciation in paired serum and CSF samples using SEC-DRC-ICP-MS and CE-ICP-DRC-MS
Michalke, B., Lucio, M., Berthele, A., & Kanawati, B. (2013) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-6662-7 · Cited by 39
The history of the research of iron in parkinsonian substantia nigra
Friedman, A., & Gałązka-Friedman, J. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0894-8 · Cited by 39
Chwiej, J. G., Adamek, D., Szczerbowska‐Boruchowska, M., Krygowska‐Wajs, A., Wojcik, S., Falkenberg, G., Manka, A., & Lankosz, M. (2006) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-006-0179-5 · Cited by 38
Szczerbowska‐Boruchowska, M., Lankosz, M., Ostachowicz, J., Adamek, D., Krygowska‐Wajs, A., Tomik, B., Szczudlik, A., Simionovici, A., & Bohic, S. (2003) · X-Ray Spectrometry · doi:10.1002/xrs.674 · Cited by 36
Considerations for measuring iron in post-mortem tissue of Parkinson’s disease patients
Hare, D. J., Gerlach, M., & Riederer, P. F. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0898-4 · Cited by 36
Monnot, A. D., Zheng, G., & Zheng, W. (2012) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.011170 · Cited by 36
Martínez-Hernández, R., Montes, S., Higuera-Calleja, J., Yescas, P., Boll, M.-C., Diaz-Ruiz, A., & Rios, C. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0535-x · Cited by 34
High precision isotope measurements reveal poor control of copper metabolism in Parkinsonism
Larner, F., Sampson, B., Rehkämper, M., Weiss, D. J., Dainty, J. R., O’Riordan, S. L., Panetta, T., & Bain, P. G. (2013) · Metallomics · doi:10.1039/c3mt20238k · Cited by 34
Parkinson's disease and other neurodegenerative disorders among welders: A Danish cohort study
Kenborg, L., Lassen, C. F., Hansen, J., & Olsen, J. H. (2012) · Movement Disorders · doi:10.1002/mds.25125 · Cited by 34
Determination of trace elements in the human substantia nigra
Morawski, M., Meinecke, C., Reinert, T., Dörffel, A. C., Riederer, P. F., Arendt, T., & Butz, T. (2005) · Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms · doi:10.1016/j.nimb.2005.01.061 · Cited by 33
Merle, U., Tuma, S., Herrmann, T. R. W., Muntean, V., Volkmann, M., Gehrke, S. G., & Stremmel, W. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.06173.x · Cited by 28
Li, X., Xie, W., Zhang, Z., Kansara, S. G., Jankovic, J. J., & Le, W. (2012) · Neurosignals · doi:10.1159/000332954 · Cited by 28
Effect of penicillamine and zinc on iron metabolism in Wilson's disease
Medici, V., Leo, V. D., Lamboglia, F., Bowlus, C. L., Tseng, S.-C., Renata D'Incà, Irato, P., Burra, P., Martines, D., & Sturniolo, G. C. (2007) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520701514495 · Cited by 28
Szczerbowska‐Boruchowska, M., Krygowska‐Wajs, A., & Adamek, D. (2012) · Journal of Physics Condensed Matter · doi:10.1088/0953-8984/24/24/244104 · Cited by 26
A case control study of CSF copper, iron and manganese in Parkinson disease
Gazzaniga, G. C., Ferraro, B., Camerlingo, M., Casto, L., Viscardi, M., & Mamoli, A. (1992) · The Italian Journal of Neurological Sciences · doi:10.1007/bf02224396 · Cited by 24
Iron Deposition after Transient Forebrain Ischemia in Rat Brain
Danielisová, V., Gottlieb, M., & Bürda, J. (2002) · Neurochemical Research · doi:10.1023/a:1014888605787 · Cited by 22
Sugawara, N., Ohta, T., Lai, Y., Sugawara, C., Yuasa, M., Nakamura, M., & Tamura, M. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00378-1 · Cited by 18
Pal, A., Vasishta, R. K., & Prasad, R. (2013) · Biological Trace Element Research · doi:10.1007/s12011-013-9753-1 · Cited by 18
High resolution quantitative element mapping of neuromelanin-containing neurons
Reinert, T., Fiedler, A., Morawski, M., & Arendt, T. (2007) · Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms · doi:10.1016/j.nimb.2007.02.070 · Cited by 13
Trace element mapping in Parkinsonian brain by quantitative ion beam microscopy
Barapatre, N., Morawski, M., Butz, T., & Reinert, T. (2010) · Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms · doi:10.1016/j.nimb.2010.02.039 · Cited by 13
Hayashi, H., Wakusawa, S., & Yano, M. (2006) · Hepatology Research · doi:10.1016/j.hepres.2006.04.008 · Cited by 6
Cited by
Environmental pollutants and their effects on human health
Shetty, S. S., D, D., S, H., Sonkusare, S., Naik, P. B., Kumari N, S., & Madhyastha, H. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e19496 · Cited by 521
Oxidative stress and cellular pathologies in Parkinson’s disease
Puspita, L., Chung, S. Y., & Shim, J.-W. (2017) · Molecular Brain · doi:10.1186/s13041-017-0340-9 · Cited by 483
Risk factors for amyotrophic lateral sclerosis
Fang, F., Ingre, C., Roos, P., Kamel, F., & Piehl, F. (2015) · Clinical Epidemiology · doi:10.2147/clep.s37505 · Cited by 462
Self-citationTriggers, Facilitators, and Aggravators: Redefining Parkinson’s Disease Pathogenesis
Johnson, M. E., Stecher, B., Labrie, V., Brundin, L., & Brundin, P. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2018.09.007 · Cited by 310
Metals and neurodegenerative diseases. A systematic review
Cicero, C. E., Mostile, G., Vasta, R., Rapisarda, V., Signorelli, S. S., Ferrante, M., Zappia, M., & Nicoletti, A. (2017) · Environmental Research · doi:10.1016/j.envres.2017.07.048 · Cited by 269
Metadata
- Authors
- Dusek, P., Roos, P. M., Litwin, T., Schneider, S. A., Flaten, T. P., & Aaseth, J.
- Venue
- Journal of Trace Elements in Medicine and Biology
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 31
- Pages
- 193-203
- ISSN
- 0946-672X (ISSN-L)
- OpenAlex
- W2025790496
- Cited by
- 253
- References
- 192
- FWCI
- 10.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.